John Jordan | Vice President of Investor Relations |
Jonathan Violin | President & Chief Executive Officer |
Barrett Katz | Chief Medical Officer |
Kristian Humer | Chief Financial Officer & Chief Business Officer |
Rami Katkhuda | LifeSci Capital |
Gavin Clark-Gartner | Evercore ISI |
Thomas Smith | SVB Securities |
Laura Chico | Wedbush Securities |
Kalpit Patel | B. Riley Securities |
Jason Butler | JMP Securities |
Greetings and welcome to Viridian Therapeutics Third Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, John Jordan, Vice President of Investor Relations.